Blog

Shares of Where Food Comes From, Inc. WFCF have declined 0.8% since reporting results for the second quarter of 2025. This compares with the S&P 500 index’s 0.7% growth over the same period. Over

Summit Therapeutics SMMT reported second-quarter 2025 loss per share of 76 cents, much wider than the Zacks Consensus Estimate of a loss of 10 cents. In the year-ago period, the company had incurred

NetEase NTES is scheduled to release second-quarter 2025 results on Aug. 14.The Zacks Consensus Estimate for NTES’ second-quarter revenues is pegged at $3.86 billion, indicating 10.02%

Shares of Genie Energy Ltd. GNE have declined 18.3% since reporting results for the second quarter of 2025, lagging the S&P 500 index’s 0.4% rise in the same period. Over the past month, the stock

Veeva Systems Inc. VEEV is well-poised for growth in the coming quarters, courtesy of its strong product portfolio. The optimism, led by a solid first-quarter fiscal 2026 performance and strategic

Investors looking for stocks in the Medical - Drugs sector might want to consider either USANA Health Sciences (USNA) or Stevanato Group (STVN). But which of these two stocks presents investors with

Investors interested in stocks from the Technology Services sector have probably already heard of Alithya Group (ALYAF) and Symbotic Inc. (SYM). But which of these two stocks offers value investors

Investors interested in stocks from the Financial - Mortgage & Related Services sector have probably already heard of Federal Agricultural Mortgage (AGM) and Zillow Group (ZG). But which of these

Investors interested in stocks from the Building Products - Miscellaneous sector have probably already heard of NWPX Infrastructure (NWPX) and Knife River (KNF). But which of these two stocks is

Investors looking for stocks in the Leisure and Recreation Products sector might want to consider either Yeti (YETI) or Pool Corp. (POOL). But which of these two companies is the best option for

CRISPR Therapeutics’ CRSP Casgevy, a one-shot gene therapy, was approved in late 2023 and early 2024 across the United States and Europe for two blood disorder indications — sickle cell disease

Investors in ABM Industries Incorporated ABM need to pay close attention to the stock based on moves in the options market lately. That is because the Oct. 17, 2025 $22.50 Call had some of the

JD.com JD is scheduled to release second-quarter 2025 results on Aug. 14.The Zacks Consensus Estimate for JD’s second-quarter revenues is pegged at $46.93 billion, indicating 17.03% year-over-year

Shares of Canterbury Park Holding Corporation CPHC have declined 2.8% since reporting results for the second quarter of 2025. This compares unfavorably with the S&P 500 index’s 0.8% growth over the

Telephone and Data Systems, Inc. TDS posted mixed second-quarter 2025 results, with top line beating the Zacks Consensus Estimate but the bottom line missing the same. TDS reported a revenue decline

Array Digital Infrastructure, Inc. USM reported strong second-quarter 2025 results, with both top and bottom lines surpassing the respective Zacks Consensus Estimate. However, the company reported a

Shares of Tucows Inc. TCX have risen 12.7% since reporting second-quarter 2025 results, outpacing the S&P 500 index’s 0.7% growth. However, over the past month, the stock has fallen 8.4%, while the

Westlake Corporation WLK reported a loss of $142 million or $1.11 per share for the second quarter of 2025. This compares to a profit of $313 million or $2.40 per share in the year-ago quarter.

Lithium stocks and ETFs jumped on Monday after the suspension of a major Chinese mine. The suspension fueled hopes of easing the global supply glut. Albemarle gained nearly 16%, its biggest one-day

Global technology solution provider Gorilla Technology Group Inc. GRRR is set to report first-half 2025 results on Aug. 14, 2025, before the opening bell.

The Zacks Consensus Estimate for

ICICI Bank IBN has been charged a monetary penalty of INR7.5 million ($85,479) by the Reserve Bank of India (“RBI”) for non-compliance with regulatory requirements.The penalty was imposed on the

Qifu Technology, Inc. QFIN is scheduled to release second-quarter 2025 results on Aug. 14, after market close.

The company surpassed the Zacks Consensus Estimate in the four trailing quarters. It

UnitedHealth Group Incorporated UNH recently reached a settlement with the DOJ to advance its $3.3 billion acquisition of home-health provider Amedisys, per reports. To resolve antitrust concerns

Spotify Technology S.A. SPOT shares have surged 105.9% in a year, surpassing the 44.9% rally of its industry and the 18.3% rise in the Zacks S&P 500 Composite.

The SPOT stock has outperformed its

The Charles Schwab Corporation’s SCHW shares have rallied 31.9% so far this year, outperforming the S&P 500 Index’s 8.5% growth and the industry’s 20.4% rise. The stock has underperformed its close